TGFB1 and neoplasm: The results showed that this treatment significantly reduced the levels of TGF-β1 and VEGF inside platelets, effectively inhibited tumor cell proliferation and platelet activation, and blocked the interaction between platelets and tumor cells, thereby successfully suppressing the migration, invasion, and EMT processes [144].